Trading Summary - March 8. A satisfactory status quo

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
197
Trading Summary - March 8.

A satisfactory status quo day for $DIGX whilst we await the PR highlighting the excellent results in the 2017 Annual Report and / or the 2018 Q1 filing.

In the meantime, 2.1M bought on the undercut ask at .0004 from either the bashers or an impatient small holder.

Typical non-effective basher paint down of 20K at .0003.

The whale bid was maintained at the more than adequate level of 80M to keep the basher / flippers boxed out from getting any more .0003s.

As the long-term followers - including at least 5 whales - control the majority of shares bought at .0003/4/5 - and they are not looking to sell anytime soon for less than the market cap - we can expect the "basher" wall to get taken out at some point - especially since a group of OTC off-the-bottom whale traders have been made aware of $DIGX now.

Watch out for any PR making the excellent performance in the 2017 Annual Report known to the wider investor / trading community.

Beyond that, the PR for the 2018 Q1 Results can be expected by around May 16, 2018 based on the 2017 schedule.

As always, anything could happen at anytime. So stay sharp if you don't already have all the shares you need to make your profit expectations on multiple runs up to end-2018 and beyond.

Prior warning and / or scanner alerts of any significant buys starting a run up will not be given on iHub but they will be alerted here immediately.

Content below the line mainly unchanged from the last update (3Q+4Q deleted / Annual inserted) - relevant to those that are new here.

The following items have not been PR'ed yet:

- Excellent 2017 Annual Report results - $1.98M Gross Revenue / $234K Net Profit.

- Further acquisition plans for brand growth.

- Shares retired in 2017 (425M known to followers here but not PR'ed yet).

In due course, the 2017 results will speak for themselves and - when PR'ed to the wider investing community - we may see serious additional new interest due to the low O/S and relatively high positive revenue for a stock in this price range - just as happened for the 2016 Q4 and the 2017 Q1 and Q2.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs throughout 2018. It is already known from posted comments and observation that at least 4 of the main whales bought shares - on the bid and on the ask - from the impatient at the end of 2017.

As predicted, at least 4 x whales who trade $DIGX continuously throughout each year were happy to take around 100M at .0003 when a few impatient people decided to trade for a loss at .0003 on December 14.

As predicted in October 2017, $DIGX was not allowed to go to the 2016 year-end low of .0002 ask at end-2017.

As predicted, the 50M+ .0004s were bought out in just 2 individual seconds and the same is likely to happen with the .0005s.at some point - setting off a run towards .0010 - just like happened in 2017 on a number of occasions.

Any shares bought at .0004 should be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q4. Shares bought at .0005 should easily return 100%+ at some point in 2018.

The big boys in DIGX now probably already have an inventory of 50M>200M each for trading throughout 2018.

Ludicrous claims by the notorious bashers on iHub - "RFB", "munimi", "surfkast:, "Crown Capital" and "Homebrew" - are clearly seen as such by all serious traders and now even by most iHubbers.

Money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.







American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 243

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading
NatGold Pulling NATG From MEXC Amid Security Concerns

Updated Category News Views 536

NatGold Digital's sudden decision to yank its NATG token off MEXC Global reeks of regulatory urgency. With the U.S. Treasury clamping down on fund transfers wrapping up MEXC in their action against Russian laundering, NatGold didn't wait for the ink to dry on that order. They’re off the exchange posthaste. A bit of foresight or sheer necessity? Well, it's got the market...

Continue Reading
Evaluating GLP-1 Telehealth? Key Questions to Consider

Updated Category News Views 565

Navigating the Landscape of GLP-1 Telehealth Providers In the sprawling jungle of telehealth options for GLP-1 care, it's easy to feel like you're drowning in sameness. Picture this: you land on a sleek page promising the moon and stars, but who knows what's behind the curtain? That's where seasoned advice comes in, like a compass in this murky digital forest. Meant, a...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 537

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Invasive Procedures Don't Extend Life in Stable Heart Disease

Updated Category News Views 477

Challenging Longstanding Beliefs Today’s news from the heart research front might set a few cardiology heads spinning. We’ve got big-time findings out of the ISCHEMIA-EXTEND study, throwing more weight on the evidence pile that early invasive heart procedures for patients with stable coronary artery disease don’t actually extend your life. Managing care with a blend...

Continue Reading
Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 446

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
Johnson & Johnson Unveils Promising PsA Treatment Data

Updated Category News Views 282

A Game-Changer in Psoriatic Arthritis Treatment? Johnson & Johnson just tossed a headline-grabbing bone into the world of psoriatic arthritis with their new ICOTYDE results. For anyone tangled in the chronic web of psoriatic arthritis, hearing about a potential new treatment like ICOTYDE comes with cautious hope. Between stiff joints and rashy skin, sufferers are often...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 34

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
J&J's New Study: Sjögren’s Solution Insight Sparks Debate

Updated Category News Views 281

Patient-Centric Take on Sjögren's Disease Johnson & Johnson has dropped fresh Phase 2 results on nipocalimab, reminding everyone they're at the helm of reshaping treatments for Sjögren's disease (SjD). A condition leaving about four million folks craving better days, in multiple ways, shines a light on what's gripping patients the hardest. It's hard not to sit up and...

Continue Reading
2027 Toy of the Year Finalists Energize Play Market

Updated Category News Views 308

A Kaleidoscope of Innovation in Toys There's a familiar buzz in the air, folks. The 2027 Toy of the Year Awards finalists have been unveiled, and they're bringing a fresh wave of creativity to children's playrooms. These aren't just toys; they're miniature innovators ready to light up the market this holiday season. The reveal happened at the Chicago Toy & Game Fair and...

Continue Reading

Top 5 Most Recently Viewed Articles

Dexcom Announces Fiscal Year 2024 Earnings Release Plans

Updated Category News Views 211

Dexcom's Upcoming Earnings Release and Conference Call Dexcom, Inc. (NASDAQ:DXCM) is excited to announce its plans for the upcoming release of its fourth quarter and fiscal year 2024 financial results. The official announcement is set for February 13, 2025, after the market closes. This is an important event for the organization and its stakeholders, providing valuable...

Continue Reading
It's Boba Time Offers Free Drinks to Honor First Responders

Updated Category News Views 433

It's Boba Time Celebrates Heroes with Complimentary Refreshments It's Boba Time, known for its delicious bubble tea and innovative beverages, is making waves in the community by honoring first responders. In a heartfelt initiative, they are offering complimentary drinks to those who serve and protect, especially during these strenuous times marked by ongoing fires...

Continue Reading
Understanding the Importance of ILD Awareness and Education

Updated Category News Views 214

Raising Awareness for Interstitial Lung Disease Each year, initiatives like ILD Day work collaboratively to raise awareness about interstitial lung disease (ILD). This important day serves as a platform to educate both the public and healthcare professionals about ILD and its various forms, including pulmonary fibrosis (PF). With over 200 diseases categorized as ILD,...

Continue Reading
Capital Health Plan’s CHAMPIONS™ Celebrates Two Decades of Fitness

Updated Category News Views 124

Capital Health Plan Celebrates 20 Years of the CHAMPIONS™ Program Capital Health Plan (CHP) has proudly marked an important milestone—the 20th anniversary of its CHAMPIONS™ Student Fitness Program. Starting at Gilchrist Elementary School, this initiative has become a staple in the community’s efforts to combat childhood obesity by promoting engaging fitness...

Continue Reading
Haystax Operations Platform Enhances Safety at Major Events

Updated Category News Views 267

Ensuring Safety with Cutting-Edge Technology at Major Events As fans gather to witness significant sporting events, the importance of public safety takes center stage. Law enforcement and emergency response teams rely on advanced technologies to maintain security, especially during large gatherings. One game-changing solution in this arena is the Haystax Common Operations...

Continue Reading